SKYE Stock Analysis: Buy, Sell, or Hold?
SKYE - Skye Bioscience, Inc. Common Stock
$0.68
-0.02 (-3.00%)
▼
5d:
-5.48%
30d:
-18.12%
90d:
+8.64%
HOLD
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When SKYE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SKYE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SKYE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SKYE is currently trading at $0.68, which is considered oversold relative to its 30-day fair value range of $0.71 to $0.80.
Technical Outlook: Technically, SKYE is showing sideways momentum. The price is currently testing key support at $0.68. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SKYE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.71 (+1036.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SKYE is showing sideways momentum. The price is currently testing key support at $0.68. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SKYE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.71 (+1036.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.71 -
$0.80
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1036.1% below Wall St target ($7.71)
- CAUTION: 5-day price weakness (-5.5%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.71 -
$0.80
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.68
Resistance Level
$0.86
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.60
Wall Street Target
$7.71
(+1036.1%)
Share & Embed Analysis
Last updated: June 25, 2026 9:05 AM ET
Data refreshes hourly during market hours. Next update: 10:05 AM
Data refreshes hourly during market hours. Next update: 10:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SKYE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 67 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 67 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 60 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$32 | 67 BUY |
